It’s up to the sponsor

TGA clarifies rules around medical termination medicines in response to question from MP The Federal Department of Health has said that changes to authority and training requirement for prescribing Mifepristone required action from current, or other potential sponsors, of the medicine and its generic alternatives.  The Department was responding to a written Question without Notice,